CAS: 84494-72-4; Ethyl Docosa-4,7,10,13,16,19-Hexaenoate

相似化合物

1191-41-9 123940-93-2 81926-94-5

上下游产品

(4Z,7Z,10Z)-13-Oxo-trideca-4,7,10-trienoic acid ethyl ester hex-5-en-2-yn-1-ol (Z,Z)-1-hydroxynona-3,6-diene Deca-4,7-diyne-1,2,10-triol(4Z,7Z,10Z,13Z,16Z,19Z)-d°Cosa-4,7,10,13,16,19-hexaen-1-yl 4-methylbenzenesulfonate d°Cosahexaenoic acid all-cis-4,7,10,13,16,19-d°Cosahexaenoic acid methyl ester methyl 3-(3-((2Z,5Z,8Z,11Z,14Z)-heptadeca-2,5,8,11,14-pentaen-1-yl)oxiran-2-yl)propanoate

乙醇,二己酸己酯置于硫酸体系中,化学反应 12.0H,以13.6 G的收率获得产物顺式-4,7,10,13,16,19二十二碳六烯酸乙酯
参考文献: Gemcitabine Prodrugs[fr] Promédicaments à Base De Gemcitabine
标题: Gemcitabine Prodrugs[fr] Promédicaments à Base De Gemcitabine
摘要:本文提供了磷酸化吉西他滨衍生的前药化合物,含有该化合物的药物组合物,以及使用这些化合物用于治疗癌症的方法.

专利信息

专利号:US-2013190399-A1
优先权日:2009-10-31
标 题:Synthesis and use of omega-3 and omega 6 very long chain polyunsaturated fatty acids (VLC-PUFA)
发明人：RAMAN KRISHNA; TARWADE VINOD
权利人:RAMAN KRISHNA; TARWADE VINOD; MARTEK BIOSCIENCES CORP
摘要:The invention provides methods of synthesizing omega-3 and omega-6 very long chain polyunsaturated fatty acids (VLC-PUFAs, C28-C42:4, 5 and 6), analogs and derivatives thereof, pharmaceutical compositions containing these isolated VLC-PUFA compounds and therapeutic uses therefor.